Skip to main content
Caplight Logo









KiOmed Pharma

KiOmed Pharma

Private
HerstalHealthcare & Life Scienceshttps://www.kiomedpharma.com/

Last Round

Early Funding

Mar 31, 2025

Total Funding Raised

$26.33M

Company Overview

KiOmed Pharma is a biotechnology company that develops, manufactures, and distributes injectable medical devices based on proprietary chitosan-derivative technology for rheumatology, aesthetic medicine, and ophthalmology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologymedical devicesviscosupplementationknee osteoarthritisinjectable implantsbiomaterialschitosan technologyorthopedic devicesintra-articular injectionanimal-free biomaterialsrheumatologyaesthetic medicineorthobiologicsjoint pain reliefbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KiOmed Pharma Comparables

Compare KiOmed Pharma with similar companies based on industry and business-model similarity.

KiOmed Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aptissen SA
89%
Contura International
81%
Avanos Medical
76%

KiOmed Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 31, 2025
Series AJun 16, 2016

Key People

Founding team and executive leadership

Houtaï Choumane

CEO & Managing Director

Executive Team

Quentin Hansenne

CFO

Executive Team

KiOmed Pharma Investors

Notable investors and investment history

KiOmed Pharma investors
InvestorRounds
NoshaqSeries A
Wallonie EntreprendreSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Monthly visitors increased 493% MoM.

  • Nov 8, 2025

    Monthly visitors increased 68% MoM.

KiOmed Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KiOmed Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KiOmed Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersHerstal
Employee Range46
Year Founded2012
Last FundingMar 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?